Celiac disease and viral B hepatitis: Lessons for clinical practice

Hepatitis Monthly

Volumn 10, Issue 4, 2010, Pages 311-312

  Tursi, Antonio ^a  

^a Servizio di Gastroenterologia Territoriale   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE; INTERFERON;

ARTICLE; CELIAC DISEASE; CHRONIC INFLAMMATION; CLINICAL PRACTICE; DRUG RESPONSE; GENETIC MARKER; GLUTEN FREE DIET; HEPATITIS B; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; INCIDENCE; INFECTION RISK; INTESTINE INJURY; PATHOGENESIS; PATIENT COMPLIANCE; REVACCINATION; SCREENING; VACCINATION;

EID: 78649364433     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Rostom A, Murray JA, Kagnoff MF. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology. 2006;131(6):1981-2002.
2. Catassi C. The world map of celiac disease. Acta Gastroenterol Latinoam. 2005;35(1):37-55.
3. Di Sabatino A, Corazza GR. Coeliac disease. Lancet. 2009;373(9673):1480-93.
4. Belloni C, Avanzini MA, De Silvestri A, et al. No evidence of autoimmunity in 6-year-old children immunized at birth with recombinant hepatitis B vaccine. Pediatrics. 2002;110(1 Pt 1):e4.
5. Desombere I, Willems A, Leroux-Roels G. Response to hepatitis B vaccine: multiple HLA genes are involved. Tissue Antigens. 1998;51(6):593-604.
6. Durupinar B, Okten G. HLA tissue types in nonresponders to hepatitis B vaccine. Indian J Pediatr. 1996;63(3):369-73.
7. McDermott AB, Zuckerman JN, Sabin CA, Marsh SG, Madrigal JA. Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination. Tissue Antigens. 1997;50(1):8-14.
8. Martinetti M, De Silvestri A, Belloni C, et al. Humoral response to recombinant hepatitis B virus vaccine at birth: role of HLA and beyond. Clin Immunol. 2000;97(3):234-40.
9. Godkin A, Davenport M, Hill AV. Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness. Hepatology. 2005;41(6):1383-90.
10. Hepatitis B vaccines: WHO position paper-recommendations. Vaccine.28(3):589-90.
11. Wasley A, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis. 2000;20(1):1-16.
12. Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol. 2004;44(1):20-9.
13. NIH Consensus Statement on Management of Hepatitis C: 2002. NIH Consens State Sci Statements. 2002;19(3):1-46.
14. Fine KD, Ogunji F, Saloum Y, Beharry S, Crippin J, Weinstein J. Celiac sprue: another autoimmune syndrome associated with hepatitis C. Am J Gastroenterol. 2001;96(1):138-45.
15. Bardella MT, Fraquelli M, Quatrini M, Molteni N, Bianchi P, Conte D. Prevalence of hypertransaminasemia in adult celiac patients and effect of gluten-free diet. Hepatology. 1995;22(3):833-6.
16. Leonardi S, La Rosa M. Are Hepatitis B Virus and Celiac Disease Linked? Hepat Mon.2010;10(3):173-5.
17. Stroffolini T, Almasio PL, Sagnelli E, Mele A, Gaeta GB. Evolving clinical landscape of chronic hepatitis B: A multicenter Italian study. J Med Virol. 2009;81(12):1999-2006.
18. Gasbarrini G, Miele L, Malandrino N, et al. Celiac disease in the 21st century: issues of under- and over-diagnosis. Int J Immunopathol Pharmacol. 2009;22(1):1-7.
19. Merat S, Rezvan H, Nouraie M, et al. Seroprevalence of hepatitis C virus: the first population-based study from Iran. Int J Infect Dis.2010[Epub ahead of Print].
20. Shalaby S, Kabbash IA, El Saleet G, Mansour N, Omar A, El Nawawy A. Hepatitis B and C viral infection: prevalence, knowledge, attitude and practice among barbers and clients in Gharbia governorate, Egypt. East Mediterr Health J.2010;16(1):10-7.
21. Sa-Nguanmoo P, Tangkijvanich P, Thawornsuk N, et al. Molecular epidemiological study of hepatitis B virus among migrant workers from Cambodia, Laos, and Myanmar to Thailand. J Med Virol.2010;82(8):1341-9.
22. Cummins AG, Roberts-Thomson IC. Prevalence of celiac disease in the Asia-Pacific region. J Gastroenterol Hepatol. 2009;24(8):1347-51.
23. Abu-Zekry M, Kryszak D, Diab M, Catassi C, Fasano A. Prevalence of celiac disease in Egyptian children disputes the east-west agriculture-dependent spread of the disease. J Pediatr Gastroenterol Nutr. 2008;47(2):136-40.
24. Hou J, Liu Z, Gu F. Epidemiology and Prevention of Hepatitis B Virus Infection. Int J Med Sci. 2005;2(1):50-7.
25. Da Villa G, Picciottoc L, Elia S, Peluso F, Montanaro F, Maisto T. Hepatitis B vaccination: universal vaccination of newborn babies and children at 12 years of age versus high risk groups. A comparison in the field. Vaccine. 1995;13(13):1240-3.
26. Noh KW, Poland GA, Murray JA. Hepatitis B vaccine nonresponse and celiac disease. Am J Gastroenterol. 2003;98(10):2289-92.
27. Park SD, Markowitz J, Pettei M, et al. Failure to respond to hepatitis B vaccine in children with celiac disease. J Pediatr Gastroenterol Nutr. 2007;44(4):431-5.
28. Nemes E, Lefler E, Szegedi L, et al. Gluten intake interferes with the humoral immune response to recombinant hepatitis B vaccine in patients with celiac disease. Pediatrics. 2008;121(6):e1570-6.
29. Ertem D, Gonen I, Tanidir C, et al. The response to hepatitis B vaccine: does it differ in celiac disease? Eur J Gastroenterol Hepatol.2010;22(7):787-93.